Upadhyay S, Kumar S, Singh V, Tiwari R, Kumar A, Sundar S
Expert Rev Mol Med. 2024; 1-55.
PMID: 39587036
PMC: 11707835.
DOI: 10.1017/erm.2024.36.
Amorim Sacramento L, Gonzalez-Lombana C, Scott P
PLoS Pathog. 2024; 20(11):e1012716.
PMID: 39527629
PMC: 11581394.
DOI: 10.1371/journal.ppat.1012716.
van Dijk N, Carter J, Kiptanui D, Pinelli E, Schallig H
Parasitology. 2024; 151(7):753-761.
PMID: 39311405
PMC: 11474019.
DOI: 10.1017/S0031182024000751.
de Alba Alvarado M, Torres Gutierrez E, Cabrera Bravo M, Zenteno Galindo E, Villarreal Munoz J, Salazar Schettino P
Pathogens. 2023; 12(9).
PMID: 37764892
PMC: 10534729.
DOI: 10.3390/pathogens12091084.
Thakur L, Madaan P, Jain A, Shankar V, Negi A, Bhushan Chauhan S
Front Immunol. 2022; 12:765684.
PMID: 35087516
PMC: 8787830.
DOI: 10.3389/fimmu.2021.765684.
Modulation of Host Immune Response during Natural Infection: A Whole-Transcriptome Analysis of the Popliteal Lymph Nodes in Dogs.
Sanz C, Miro G, Sevane N, Reyes-Palomares A, Dunner S
Front Immunol. 2022; 12:794627.
PMID: 35058931
PMC: 8763708.
DOI: 10.3389/fimmu.2021.794627.
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
Volpedo G, Pacheco-Fernandez T, Bhattacharya P, Oljuskin T, Dey R, Gannavaram S
Front Immunol. 2021; 12:748325.
PMID: 34712235
PMC: 8546207.
DOI: 10.3389/fimmu.2021.748325.
Modulation of Splenic B Cell Subsets during Experimental Infection in BALB/c Mice.
Mondal K, Das S, Naskar K, Roy S
Pathogens. 2021; 10(7).
PMID: 34209841
PMC: 8308600.
DOI: 10.3390/pathogens10070814.
Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.
Jesus J, Sousa I, da Silva T, Ferreira A, Laurenti M, Antonangelo L
Pharmaceutics. 2021; 13(6).
PMID: 34205283
PMC: 8235317.
DOI: 10.3390/pharmaceutics13060908.
Revival of Leishmanization and Leishmanin.
Pacheco-Fernandez T, Volpedo G, Gannavaram S, Bhattacharya P, Dey R, Satoskar A
Front Cell Infect Microbiol. 2021; 11:639801.
PMID: 33816344
PMC: 8010169.
DOI: 10.3389/fcimb.2021.639801.
Immune Responses in Post Kala-azar Dermal Leishmaniasis.
Chatterjee M, Sengupta R, Mukhopadhyay D, Mukherjee S, Dighal A, Moulik S
Indian J Dermatol. 2021; 65(6):452-460.
PMID: 33487699
PMC: 7810083.
DOI: 10.4103/ijd.IJD_258_20.
Good's syndrome and recurrent leishmaniasis: A case report and review of literature.
Tolomeo M, Bonura S, Abbott M, Anastasia A, Colomba C, Cascio A
Heliyon. 2020; 6(9):e05061.
PMID: 33024862
PMC: 7527582.
DOI: 10.1016/j.heliyon.2020.e05061.
activity of extract against the promastigote stage of cutaneous parasite, a member of complex isolates from Ghana.
Anning A, Kwakye-Nuako G, Ameyaw E, Mosore M, Asare K
Access Microbiol. 2020; 1(7):e000050.
PMID: 32974542
PMC: 7481739.
DOI: 10.1099/acmi.0.000050.
Cytokine profile in Leishmania-positive blood donors.
de Oliveira Franca A, Soares L, Pompilio M, Tozetti I, Bonin C, Dorval M
PLoS One. 2020; 15(9):e0238933.
PMID: 32966326
PMC: 7511012.
DOI: 10.1371/journal.pone.0238933.
Case Report: Severe Visceral Leishmaniasis in a Patient with HIV Coinfection Undergoing Treatment for Erythema Nodosum Leprosum.
Aquino S, Diniz L, Queiroz I, Cunha M, Justo A, Silva E
Am J Trop Med Hyg. 2020; 103(6):2253-2256.
PMID: 32901606
PMC: 7695079.
DOI: 10.4269/ajtmh.20-0567.
Post kala-azar dermal leishmaniasis: A threat to elimination program.
Gedda M, Singh B, Kumar D, Singh A, Madhukar P, Upadhyay S
PLoS Negl Trop Dis. 2020; 14(7):e0008221.
PMID: 32614818
PMC: 7332242.
DOI: 10.1371/journal.pntd.0008221.
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
Rabi Das V, Bimal S, Siddiqui N, Kumar A, Pandey K, Sinha S
PLoS Negl Trop Dis. 2020; 14(6):e0008272.
PMID: 32555598
PMC: 7326279.
DOI: 10.1371/journal.pntd.0008272.
TLR4 abrogates the Th1 immune response through IRF1 and IFN-β to prevent immunopathology during L. infantum infection.
Amorim Sacramento L, Benevides L, Maruyama S, Tavares L, Fukutani K, Francozo M
PLoS Pathog. 2020; 16(3):e1008435.
PMID: 32210480
PMC: 7135367.
DOI: 10.1371/journal.ppat.1008435.
Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.
Romanelli M, da Costa-Silva T, Cunha-Junior E, Dias Ferreira D, Guerra J, Jimenez Galisteo Jr A
Front Cell Infect Microbiol. 2019; 9:353.
PMID: 31737574
PMC: 6828611.
DOI: 10.3389/fcimb.2019.00353.
Antileishmanial activity and immunomodulatory effect of subamolide, a butanolide isolated from (Lauraceae).
da Costa-Silva T, Alves Conserva G, Galisteo Jr A, Tempone A, Lago J
J Venom Anim Toxins Incl Trop Dis. 2019; 25:e20190008.
PMID: 31467511
PMC: 6707387.
DOI: 10.1590/1678-9199-JVATITD-2019-0008.